Industrial Technology Research Institute

Hsin-Chieh Wu

I-Hong Pan

I-Horng Pan

Chu-Hsun Lu

Shu-Fang Wen

Hsin-Jan Yao

I-Huang Lu

Wei-Hsuan Hsu

Lain-Tze Lee

Jir-Mehng Lo

Yi-Cheng Cheng

Zong-Keng Kuo

Tien-Soung Tong

Chi-Chien Lin

Der-Yuan Chen

Ming-Han Li

Hsiang-Wen Tseng

Mei-Wei Lin

Ching Te Lu

Jaw-Ji Tsai

Shyh-Horng Lin

Ching-Huai Ko

Yih-Loong Lai

Shih Cheng Shen

Nai-Yun Hsu

Sheau-Ni Su

Sue-Fen Jiang

Rong-Ming Lyu

Joung-Liang Lan

Chun-Chung Wang

A method for treating and/or alleviating nervous diseases is provided. The method for treating and/or alleviating nervous diseases includes: administering an effective amount of a water extract of a plant of Gracilariaceae or a ferment thereof to a subject in need thereof to treat and/or alleviate a nervous disease thereof, wherein the ferment of the water extract of a plant of Gracilariaceae is a lactic acid bacteria ferment.

Pharmaceutical composition or health food for treating and/or alleviating nervous diseases

The present disclosure provides a method for treating and/or alleviating nervous diseases, including: administering an effective amount of a water extract of a plant of Gracilariaceae or a ferment thereof to a subject in need thereof to treat and/or alleviate a nervous disease thereof, wherein the ferment of the water extract of a plant of Gracilariaceae is a lactic acid bacteria ferment.

Application for water extract of plant ofor ferment thereof and pharmaceutical composition and/or health food for treating and/or alleviating nervous diseases

The disclosure provides a pharmaceutical composition for inhibiting angiogenesis, including an effective amount of an extract ofor an effective amount of a lignan as an effective ingredient. The pharmaceutical composition may further include a pharmaceutically acceptable carrier or salt. The disclosure also provides a method for inhibiting angiogenesis, including administering an effective amount of an extract ofor an effective amount of a lignan as an effective ingredient for inhibiting angiogenesis to a subject in need thereof.

Pharmaceutical compositions and method for inhibiting angiogenesis

The disclosure provides a method for modulating Th17 cells, including: administering an(also namedor) extract to a subject in need thereof, wherein theextract has an effect of modulating Th17 cells. Theextract may include a fruiting body extract ofor a mycelium extract of

Method for modulating Th17 cells and method for treating a disease related to modulation of Th17 cells

Pharmaceutical compositions for treating immunological disorders and the preparing method of the same are disclosed, which include alcohol extracts of(schw) Wolf, and. The compositions are manufactured by novel procedures consisting of decocting using specific concentration ranges of alcohol, filtering, regulating pH value, purifying, concentrating, proportionally mixing, and making a granule powder from lyophilized extract. This invention used both in vitro and in vivo assays to evaluate therapeutic effects of specific combination of herbal plant extracts. The combination of herbal extracts has been able to maximize the anti-inflammatory activity and regulate the secretion of cytokines such as eotaxin and IL-4. When the pharmaceutical composition of the present invention is used for asthma, it can relieve coughs, resist airway allergic inflammation reactions, improve the pulmonary functions, reduce allergen specific IgE in bloods, stabilize elasmatoblasts, and stop the attacks from asthma.

Herbal composition for treating allergic disorders and method for making the same

Growing community of inventors

Hsinchu, Taiwan

Hsin-Chieh Wu